The antibody therapy market is anticipated to expand at a consistent CAGR of 13.4% throughout the course of the projected period. The market is projected to be valued US$ 824.0 billion by 2033, from its 2023 valuation of US$ 235 billion. Higher penetration of adverse diseases like cancer, and COVID-19 spread, has fueled the demand …